Literature DB >> 19032154

Short-hairpin-RNA-mediated silencing of fucosyltransferase 8 in Chinese-hamster ovary cells for the production of antibodies with enhanced antibody immune effector function.

Vincent Beuger1, Klaus-Peter Künkele, Hans Koll, Achim Gärtner, Monika Bähner, Helmut Burtscher, Christian Klein.   

Abstract

Antibody-producing Chinese-hamster ovary cells (CHO-DG44) were converted into cells producing antibodies with strongly enhanced ADCC (antibody-dependent cellular cytotoxicity) by knocking down FuT8 (alpha-1,6-fucosyltransferase or fucosyltransferase 8) via constitutive expression of shRNA (short-hairpin RNA) against FuT8. After the introduction of a FuT8 shRNA expression plasmid under the control of a U6 promoter, CHO-DG44 clones with less than 5% residual FuT8 mRNA expression were isolated by selection for neomycin resistance, followed by low affinity nerve growth factor receptor enrichment and selection for LCA [Lens culinaris (culinary lentil) agglutinin] resistance. The CHO-DG44 clones identified produced highly afucosylated anti-[IGF-1R (insulin-like-growth-factor-1 receptor)] antibodies (up to 88%) that exhibited considerably enhanced ADCC compared with anti-IGF-1R wild-type antibodies produced by parental CHO cells. At the same time, antibody productivity was not significantly decreased. Analysis of stability showed that the clones obtained may be suitable for up-scaling, since low residual levels of FuT8 mRNA and production of afucosylated antibodies were maintained for at least 4 weeks.

Entities:  

Mesh:

Substances:

Year:  2009        PMID: 19032154     DOI: 10.1042/BA20080220

Source DB:  PubMed          Journal:  Biotechnol Appl Biochem        ISSN: 0885-4513            Impact factor:   2.431


  9 in total

Review 1.  Genomics in mammalian cell culture bioprocessing.

Authors:  Diane M Wuest; Sarah W Harcum; Kelvin H Lee
Journal:  Biotechnol Adv       Date:  2011-11-04       Impact factor: 14.227

2.  Fluorescent Citrine-IgG fusion proteins produced in mammalian cells.

Authors:  Alexander K Haas; Christoffer von Schwerin; Daniela Matscheko; Ulrich Brinkmann
Journal:  MAbs       Date:  2010-11-01       Impact factor: 5.857

3.  Glycoengineered Pichia produced anti-HER2 is comparable to trastuzumab in preclinical study.

Authors:  Ningyan Zhang; Liming Liu; Calin Dan Dumitru; Nga Rewa Houston Cummings; Michael Cukan; Youwei Jiang; Yuan Li; Fang Li; Teresa Mitchell; Muralidhar R Mallem; Yangsi Ou; Rohan N Patel; Kim Vo; Hui Wang; Irina Burnina; Byung-Kwon Choi; Hans E Huber; Terrance A Stadheim; Dongxing Zha
Journal:  MAbs       Date:  2011-05-01       Impact factor: 5.857

4.  Glycoengineering of Mammalian Expression Systems on a Cellular Level.

Authors:  Kelley M Heffner; Qiong Wang; Deniz Baycin Hizal; Özge Can; Michael J Betenbaugh
Journal:  Adv Biochem Eng Biotechnol       Date:  2021       Impact factor: 2.635

5.  Bispecific digoxigenin-binding antibodies for targeted payload delivery.

Authors:  Silke Metz; Alexander K Haas; Karin Daub; Rebecca Croasdale; Jan Stracke; Wilma Lau; Guy Georges; Hans-Peter Josel; Sebastian Dziadek; Karl-Peter Hopfner; Alfred Lammens; Werner Scheuer; Eike Hoffmann; Olaf Mundigl; Ulrich Brinkmann
Journal:  Proc Natl Acad Sci U S A       Date:  2011-05-02       Impact factor: 11.205

6.  Rapid Antibody Glycoengineering in CHO Cells Via RNA Interference and CGE-LIF N-Glycomics.

Authors:  Pavlos Kotidis; Masue Marbiah; Roberto Donini; Itzcóatl A Gómez; Ioscani Jimenez Del Val; Stuart M Haslam; Karen M Polizzi; Cleo Kontoravdi
Journal:  Methods Mol Biol       Date:  2022

Review 7.  Glycoengineering Chinese hamster ovary cells: a short history.

Authors:  Roberto Donini; Stuart M Haslam; Cleo Kontoravdi
Journal:  Biochem Soc Trans       Date:  2021-04-30       Impact factor: 5.407

8.  Molecular cloning, characterization, genomic organization and promoter analysis of the α1,6-fucosyltransferase gene (fut8) expressed in the rat hybridoma cell line YB2/0.

Authors:  Béatrice Teylaert; Edwige Meurice; Marie Bobowski; Anne Harduin-Lepers; Christine Gaucher; Alexandre Fontayne; Sylvie Jorieux; Philippe Delannoy
Journal:  BMC Biotechnol       Date:  2011-01-05       Impact factor: 2.563

9.  Exploitation of the ribosomal protein L10 R98S mutation to enhance recombinant protein production in mammalian cells.

Authors:  Benno Verbelen; Tiziana Girardi; Sergey O Sulima; Stijn Vereecke; Paulien Verstraete; Jelle Verbeeck; Jonathan Royaert; Sonia Cinque; Lorenzo Montanaro; Marianna Penzo; Maya Imbrechts; Nick Geukens; Thomas Geuens; Koen Dierckx; Daniele Pepe; Kim Kampen; Kim De Keersmaecker
Journal:  Eng Life Sci       Date:  2022-01-14       Impact factor: 2.678

  9 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.